Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OncoCyte Corp OCX

Healthcare Biotechnology
Oncocyte Corporation is a precision diagnostics company. The Company is engaged in the development of Oncocytes tests and the acquisition of proprietary molecular technologies in the fields of oncology and transplantation. The Company’s products include DetermaIO, VitaGraft, DetermaCNI and GraftAssure. DetermaIO is a gene expression test that assesses the tumor microenvironment to predict... see more

Recent & Breaking News (NDAQ:OCX)

Oncocyte Announces Formation of Medical Advisory Board

GlobeNewswire March 9, 2021

Oncocyte Announces Agreement with MultiPlan Network, Expanding Patient Access to DetermaRx(TM)

GlobeNewswire March 4, 2021

Oncocyte to Report Fourth Quarter and Full Year 2020 Financial Results on Tuesday, March 16

GlobeNewswire March 3, 2021

Oncocyte Closes Second Investment In Razor Genomics to Complete Acquisition

GlobeNewswire February 25, 2021

Oncocyte to Begin Trading on the Nasdaq Stock Market on March 8, 2021

GlobeNewswire February 23, 2021

Oncocyte to Participate in Fireside Chat at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

GlobeNewswire February 16, 2021

Oncocyte Announces Closing of $40 Million Public Offering of Common Stock

GlobeNewswire February 9, 2021

Oncocyte Announces Pricing of $35 Million Public Offering of Common Stock

GlobeNewswire February 5, 2021

Oncocyte Announces Proposed Public Offering of Common Stock

GlobeNewswire February 4, 2021

Oncocyte Announces Definitive Agreement to Acquire Chronix Biomedical, Inc.

GlobeNewswire February 2, 2021

Oncocyte to Present New Data at the IASLC 2020 World Conference on Lung Cancer

GlobeNewswire January 28, 2021

Oncocyte Announces $25 Million Registered Offering

GlobeNewswire January 20, 2021

Oncocyte to Present at the 23rd Annual Needham Virtual Growth Conference

GlobeNewswire January 12, 2021

Oncocyte to Present at the 15th Annual LD Micro Main Event

GlobeNewswire December 15, 2020

Oncocyte and Burning Rock Execute Strategic Agreement to Distribute DetermaRx in China

GlobeNewswire December 15, 2020

Burning Rock Announces an Exclusive in-Licensing of a Risk Stratification Test for Early Stage Lung-Cancer Patients from Oncocyte in China

GlobeNewswire December 15, 2020

Oncocyte Corporation Hosting Key Opinion Leader Call on Proprietary Molecular Tests for Cancer Treatment Selection

GlobeNewswire December 7, 2020

Oncocyte to Participate at 32nd Annual Piper Sandler Virtual Healthcare Conference

GlobeNewswire November 18, 2020

Oncocyte Presents New Data on Its DetermaIO(TM) Test at Association for Molecular Pathology (AMP) 2020 Conference

GlobeNewswire November 18, 2020

Oncocyte Reports Third Quarter 2020 Financial Results and Provides Corporate Update

GlobeNewswire November 12, 2020